CANNABIS CAMPAIGN: USERS' STORIES HELP MEDICAL RESEARCH

IN AN unprecedented arrangement with the Home Office, Dr Geoffrey Guy, the
entrepreneur licensed to farm cannabis in Britain for medical research,
will now be able to make use of the experience of patients who have been
taking the drug illegally.

The doctor has been advised that patients who find their symptoms are
alleviated by cannabis will not be liable for prosecution as long as they
contact him through their own doctors. His company, GW Pharmaceuticals,
will then be able to use their evidence to direct its own research.

"Over many years a whole wealth of research has been going on illegally in
the homes of sufferers all over the country," said Dr Guy. "The difficulty
has been finding a way of tapping this information for the use of the
scientific community."

The Home Office permission means that doctor/patient confidentiality will
be maintained and people with illnesses such as multiple sclerosis, cancer,
Aids or glaucoma will be able to communicate their knowledge of the
therapeutic value of the drug without fear of prosecution.

The agreement follows up the work of the newspaper Disability Now and the
campaigning group Alliance for Cannabis Therapeutics which last month
joined together to help Dr Guy set up a register of sufferers who could
take part in clinical trials.

In this month's issue of Disability Now, published by the charity Scope,
disabled readers are being encouraged to consider taking part in the
Government-backed trials. The journal's support for Dr Guyfollows a reader
survey last year in which nearly 98 per cent of respondents backed the
legalisation of the drug and 67 per cent had taken cannabis for medicinal
purposes.

Dr Guy believes the opportunity to investigate anecdotal evidence is
invaluable. "We now have a legal framework to make enquiries into patient
groups," he said. Patients can contact Dr Guy through Disability Now at 6
Market Road, London N7 9PW.

e-mail your comments to cannabis@independent.co.uk

Checked-by: (Joel W. Johnson)